[office practice] Step Up To Residency. Objectives Enhance knowledge of office based obgyn practice through a simulated patient case Practice skills you.

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

Dr Kristina Naidoo Consultant Gynaecologist
What’s New in Adolescent Contraception? Rachel S-D Fortune, MD, FAAP Medical Director, Newport Academy.
Periodic Woman Screening Sheet By Periodic Woman Screening Committee January 2010.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Gynecologic Cancers Presented by: Michael Goodheart, MD Assistant Professor Gynecologic Oncology The University of Iowa Hospitals & Clinics Understanding,
IL BCCP Questions.
Updates on Pap Smear Guidelines 2014
ABNORMAL UTERINE BLEEDING Dr Rooma Sinha, MD, DNB Senior Consultant Gynecologist & Laparoscopic Surgeon Apollo Health City; HYDERABAD
Abnormal Vaginal Bleeding in a 56 year old Max Brinsmead PhD FRANZCOG May 2015.
Abnormal uterine bleeding
DYSFUNCTIONAL UTERINE BLEEDING
Spotlight on Cervical Cancer Screening
Abnormal Uterine Bleeding
Benign and premalignant disease of the cervix
Abnormal Uterine Bleeding
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Post Menopausal Bleeding
Dr. HANA OMER Abnormal Uterine Bleeding (AUB) 2014.
UTERINE FIBROIDS Hazem Al-Mandeel, M.D Course 481 Obstetrics and Gynecology Rotation.
Women's Health ISU Student Health Promotions
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
Cervical Cancer Screening
DR MANAL IDRIS menorrhagia. Introduction Menorrhagia is one of the commenest gynaecological complaints seen in practice and accounts for approximately.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Screening Tests for Brest & Cervical Cancer
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Normal and Abnormal Uterine Bleeding
Academic Year MSIII Ob/Gyn Clerkship Self-Directed Study
Exams and tests for vaginal bleeding. 1.Your health care provider will take a careful medical history. You will be asked questions about the following.
Early Pregnancy Loss.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 1 Abnormal Bleeding CAPT Mike Hughey, MC, USNR.
Clinical Oral Presentation Jessica Ward.  “I committed myself to the proactive stance of health promotion and disease prevention with the conviction.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Component 3-Terminology in Healthcare and Public Health Settings
TPMG CME Conference 2015 Jeff Morrison, DO. Searched for New Patient visits and Consults to TPMG Ob/Gyn in 2013 and Patient visits Menorrhagia.
OVARIAN CANCER RISK FACTORS Studies have found the following risk factors for ovarian cancer:  Family history of cancer: Women who have a mother, daughter,
ABNORMAL UTERINE BLEEDING
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
Cervical Intraepithelial Neoplasm
Abnormal uterine bleeding King Khalid University Hospital Department of Obstetrics & Gynecology Course 481 Tutorials.
Max Brinsmead MB BS PhD May The common causes are…  Pregnancy-related ○ Miscarriage – threatened, inevitable or incomplete ○ Ectopic  Cervical.
Prof Lindeque Abnormal excessive uterine bleeding.
ABNORMAL UTERINE BLEEDING IN REPRODUCTIVE AGED WOMEN August 2015 Hoa Nguyen Jodi Nagelberg John Joseph Kimberly Truong Rola Khedraki Sangeeta Kalsi.
Vaginal Bleeding in the Perimenopause (Age 35-50)
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Abnormal Uterine Bleeding Case Studies
Cervical Cancer Screening and Sexually Transmitted Infection Case Study PCP version
Better Health. No Hassles. Ovarian Cancer Sokan Hunro, PAC, MPH.
SCREENING IN GYNECOLOGICAL CANCER Taravat Fakheri OB/GYN KUMS.
Post menopausal bleeding
To pap or not to pap: and what to do when you do Kimberly Swan MD Minimally Invasive Gynecologic Surgery Assistant Professor Ob/Gyn University of Kansas.
Cytopathology Feb
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Approach to Abnormal Uterine Bleeding
Abnormal Uterine Bleeding
Changes before the change: Perimenopausal Bleeding
Functional and symptomatic abnormal uterine bleeding
Endometrial hyperplasia
Post Menopausal Bleeding
Changes before the change: Perimenopausal Bleeding
Kelly Murguia, MSN, NP Reedley College Health Services Coordinator
Abnormal Bleeding CAPT Mike Hughey, MC, USNR.
Changes before the change: Perimenopausal Bleeding
Step Up To Residency Objectives Milestones in Office Practice
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
SH-sheikhhasani Gyn-oncologist
Presentation transcript:

[office practice] Step Up To Residency

Objectives Enhance knowledge of office based obgyn practice through a simulated patient case Practice skills you will use early on during office based encounters Discuss self-directed learning and critical appraisal of medical literature Understand the importance of communication with patients, family and other members of the healthcare team

Milestones in Office Practice Demonstrates basic knowledge about what constitutes normal and abnormal uterine bleeding Verbalizes the phases of the normal menstrual cycle Verbalizes basic knowledge about common contraceptive options Demonstrates basic knowledge about common ambulatory gynecologic problems

Milestones in Office Practice Demonstrates an understanding of common non-reproductive medical disorders Demonstrates knowledge of the characteristics of a good screening test Demonstrates knowledge of indications and limitations of commonly used screening tests Demonstrates an understanding of critical appraisal of the literature

Milestones in Office Practice Demonstrates adequate listening skills Communicates effectively in routine clinical situations Understands the importance of relationship development, information gathering and sharing Understands the importance of informed consent

Office Practice Case Simulation A 46 year old G4P3013 presents to your office with complaint of heavy vaginal bleeding for the past 3 weeks.

What are key elements in the history?

Full gyn history including STIs and pap history Details about menstrual history and current bleeding pattern/ associated pain PMH/ PSH Current medications Current contraception or fertility desires Targeted family history Smoking history Review of Systems

Office Practice Case Simulation Gyn history – menarche age 11/ menses monthly/7-10 days – No STIs, in monogamous relationship for 15 years – Last pap 5 years ago and was normal – Mammogram 6 mo ago - normal Bleeding history – Heavy x 6 mo – Increased dysmenorrhea PMH – none PSH – D&C at age 30 for a missed abortion

Office Practice Case Simulation Medications – multivitamin Contraception – Condoms but would like to discuss other options Family history – Colon cancer: m. grandmother – HTN: father Social history – No tobacco use, 1 drink / week ETOH, no drug use ROS – 10 lb weight gain in 1 yr – Increased fatigue for 2 mo

Review of menstrual cycle

Hormonal effects on endometrium Estrogen is the fertilizer – Allows endometrial proliferation Progesterone is the lawn mower – Keeps lining thin

What are key elements in the physical?

Vital signs Thyroid exam Abdominal exam Pelvic exam – Pap smear – Endometrial biopsy – Consider gonorrhea/ chlamydia testing

Office Practice Case Simulation Hands on Exercise: Perform a pelvic exam (external exam, speculum exam, bimanual exam and collection of pap) Faculty will review key point and Pearls related to the pelvic exam

Review of cervical cancer screening Begin screening at age 21 Screen every 3 years ages Screen every 5 years for ages 30 and over if pap and HPV testing combined, if pap alone then every 3 years Women with history of CIN 2 or 3 should receive screening for at least 20 years May stop screening at age 65 if last 3 paps normal and no abnormal paps in past 10 years May stop screening if hysterectomy has been done for benign indications and no prior history of high grade cervical dysplasia

Human Papilloma Virus DNA viruses – Low oncogenic – High oncogenic (16 and 18 responsible for 70% cervical cancer in US) Most Transient – 50% cleared 8 mo – 90% cleared 2 yr Infects immature basal cells at squamocolumnar junction

Abnormal Cervical Cytology (Age 25 and over) Atypical Squamous Cells of Undetermined Significance (ASC-US) HPV negHPV pos Repeat pap 3 yrCOLPOSCOPY Low Grade Squamous Intraepithelial Lesion (LSIL) COLPOSCOPY High Grade Squamous Intraepithelial Lesion (HSIL) COLPOSCOPY

Abnormal Cervical Cytology (Age 21-24) Atypical Squamous Cells of Undetermined Significance (ASC-US) HPV negHPV pos or unknown (preferred) Repeat pap 3 yrRepeat pap 1 yr Low Grade Squamous Intraepithelial Lesion (LSIL) repeat pap 1 yr High Grade Squamous Intraepithelial Lesion (HSIL) COLPOSCOPY

Principles of a Screening Test Identifies a clinically significant disease that has a preclinical state – Results in significant morbidity or mortality if left untreated – A treatment must exist Test is reasonably priced Test is non invasive

Principles of a Screening Test Test is sensitive – Correctly identifies patients with the disease Test is specific – Correctly identifies patients without the disease

Review of the endometrial biopsy Abnormal Uterine Bleeding (AUB) Indication for endometrial biopsy >45 yo<45 yo * unopposed estrogen (obesity/ PCOS) * failed medical mgmt * persistent AUB Diagnosis of AUB in Reproductive-Aged Women, ACOG Practice Bulletin 128

Office Practice Case Simulation Your faculty facilitator will review key point and Pearls related to performing an endometrial biopsy Perform endometrial biopsy simulation

Office Practice Case Simulation Vitals – Temp 37.4, BP 122/74, BMI 28 kg/ m2, pulse 72 – Urine pregnancy test is negative Neck – No thyromegaly Abdomen – Soft, non-tender, non-distended, no hernias or masses, normal bowel sounds

Office Practice Case Simulation Pelvic – Normal external genitalia – Urethral meatus appears normal – Vaginal mucosa without lesion, moderate blood in vault – Cervix without gross lesions – Uterus normal size, shape and contour, no masses – No adnexal masses or tenderness

What is your Differential Diagnosis?

* Always r/o pregnancy Abnormal Uterine Bleeding (AUB) Heavy menstrual bleeding (AUB/HMB) Intermenstrual bleeding (AUB/IMB) COEIN: Non-structural Causes Coagulopathy (AUB-C) Ovulatory dysfunction (AUB-O) Endometrial (AUB-E) Iatrogenic (AUB-I) Not yet classified (AUB-N) PALM: Structural Causes Polyp (AUB-P) Adenomyosis (AUB-A) Leiomyoma (AUB-L) Submucosal myoma (AUB-L ) Other myoma (AUB-L ) Malignancy & hyperplasia (AUB-M) SM O

What additional work-up do you want?

TSH CBC Pelvic ultrasound You schedule a follow up appointment to discuss all results and further management in 2 weeks

Follow-up Visit Your patient reports that her bleeding finally stopped about 5 days ago. She has no new complaints. Labs – TSH: 3.5 mIU/ml ( normal: 0.4-5mIU/ml) – Hemoglobin: 10 g/dL – Endometrial biopsy: benign secretory endometrium – Pap: ASCUS, HPV neg – Gonorrhea: neg Chlamydia: neg

Ultrasound The uterus is anteverted and measures 8 x 6 x 5 cm. The endometrial stripe measures 8 mm. The ovaries appear normal.

Management Given the evaluation results, what management options would you discuss with this patient who has AUB and also desires contraception?

Management Mirena IUD Combination OCP Oral progesterone (continuous vs cyclic) DMPA BTL and endometrial ablation

Communication/ Relationship Development Introduce yourself Sit down Make eye contact Allow the patient to talk Summarize what you are hearing from them Summarize your plan Ask them if they understand the management care plan

Review of Contraception Mechanism of Action – Progestin – Negative feedback on LH – Increase cervical mucus – Prevents capacitation of sperm – Estrogen – Suppresses release of FSH – Accelerates ovum transport

Review of Contraception Review as a group the benefits, disadvantages and contraindications for each of the following: – Combination OCP – Progesterone only OCP – Ortho-Evra patch – Nuvaring – DMPA – Nexplanon – Mirena/ Skyla IUD – Paragard IUD

Office Practice Case Simulation Your patient elects for a Mirena IUD: Discuss how you would consent your patient for this procedure

Review of Informed Consent Elements of informed consent – The nature of the decision/procedure – Reasonable alternatives to the proposed intervention – The relevant risks, benefits, and uncertainties related to each alternative – Assessment of patient understanding – The acceptance of the intervention by the patient Reasonable patient standard – What would the average patient need to know in order to be an informed participant in the decision?

Office Practice Case Simulation Your faculty facilitator will review key point and Pearls related to Mirena IUD insertion Perform IUD insertion simulation

Self- Directed Learning Critical Appraisal of Literature As a good resident, you like to read each night about something you saw that day. You are wondering if a Mirena IUD is really that effective at controlling AUB.

Critical Appraisal of the Literature Reporting – Purpose and hypothesis clearly stated? – Is the study relevant? Study design – Prospective vs. retrospective? – Randomized? – Appropriate controls? – Reproducible? – Applicable to your patient population?

Critical Appraisal of the Literature Execution of study – Adequate sample size? – Confounding variables? – Attrition rate/ appropriate f/u time? – Appropriate statistics? Assessment of conclusion – Do findings support conclusions? – Clinical vs. statistical significance? Application – Is this helpful to your practice? – Ideas for future research?

Thank you for your participation Remember to fill out your post course evaluation prior to leaving!